Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
Recruiting · NCT07265323 · Interventional (participants receive a specific treatment) · Lead sponsor: Pennington Biomedical Research Center
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to determine if a weekly delivery of insulin at short intervals lasting up to 2 hours can improve insulin sensitivity and cognition in adults with Alzheimer's Disease. It will also provide information about the safety and feasibility of this intervention. The main questions it aims to answer are: Does the intervention improve insulin sensitivity (how the body uses glucose)? Does the intervention improve cognition, measured by the Montreal Cognitive Assessment (MoCA) and the Revised Memory and Behavior Problems Checklist (RMBPC)? What changes occur in brain glucose uptake (FDG-PET)? Participants will: Receive the intervention once a week for 6 months, with each session lasting up to 2 hours Complete cognitive assessments. Adverse events will be assessed throughout the study.
Who can take part
Inclusion criteria
- Mini Mental State Examination (MMSE) score \< 25
Exclusion criteria
- On daily medication for the specific treatment of anxiety including benzodiazepines.
- An infant, child, or teenager
- A pregnant woman
- A prisoner
- Having any condition that impedes testing of the study hypothesis or are otherwise deemed to be unsuitable (determined by the investigative team).
Where it is running
1 location listed across 1 US state.
- Pennington Biomedical Research Center - Baton Rouge, Louisiana, United States